NRP1 and glioblastoma: Lastly, we discuss Neuropillin 1 (NRP1), a prominent cell surface protein receptor with many distinct ligands, as a potential therapeutic target across immune cell populations, and suggest that NRP1 could be exploited in developing new treatments for GBM.